SOD1 and mild neurocognitive disorder: These transgenic mice express the human SOD1 disease variant containing an alanine for glycine mutation at amino acid 93 leading to symptoms of MND beginning at 150 days and resulting in 100% mortality by approximately day 170 (10–12).